Research on the Menopause in the 1990's, WHO Technical Report Series #866 (1999). |
Pola P, Savi L, Grill M, and Lago A. Carnitine in the Therapy of Dyslipidemic Patients, Curr. Ther. Res. 1980. 27: pp. 208-216. |
Lacour B, Chanard J, Haguet M, DiGuilio S, et al. Carnitine Imporves Lipid Anomalies in Haemodialysis Patients, Lancet 1980. pp. 763-764. |
Avogaro P, Bon GB, Cazzaloato G, Rorai E. Acute Effects on L-Carnitine on FFA and beta-hydroxy-butyrate in Man Pharmacol Res. Commun. 1981. 13: pp. 443-450. |
Vacha GM, Giorcelli G, Silliprandi N, Corsi M. Favorable Effects of L-Carnitine Treatment on hypertriglyceridemia in hemodialysis patients: Decisive role of low levels of high density Lipoprotein-Chelosterol, Am J Clin Nutr 1983, pp. 532-540. |
Arduini A, Dottori S, Sciarroni AF, et al. Effect of Propionyl-L-Carnitine treatment on membrance phospholipid fatty acid turnover in diabetic Rat Erythrocytes, Mol Cell Biochem 1995, pp. 31-37. |
Arduini A, Bressen M, Sciarron F, et al. Carnitine palmitoyltransferase and acyl-CoA binding protein: two more players in the membrance phospholipid fatty acid turnover of human red cells. Biochemical Journal (1997), 325: pp. 811-814. |
Adruni A, Holme S, Sweeney JD, et al. Addition of L-caratine to additive solution-suspended red cells stored at 4°C reduces in vitro hemolysis and improves in vivo viability. Transfusion, 1997, 37: pp. 166-174. |
Schinetti ML, Rossini D, Greco R, Bertelli A. Protective action of acetylcarnitine on NADPH-inducded lipid peroxidation of cardiac microsomes. Drugs Exptl. Clin. Res. 1987, 8:pp. 509-515. |
Calabrese V and Rizza V. Effects of L-carnitine on the formation of fatty acid ethyl esters in brain and peripheral organs after short-term ethanol administration in rat. Neurochemical Research, 1999, 24:pp. 79-84. |
Paulson DJ, Shug AL, Zhao J. Protection of the ischemic diabetic heart by L-propionyl carnitine therapy. Molecular and Cellular Biochemistry, 1992, 116:pp. 131-137. |
Kalaislvi T, Panneerselvam C. Effect of L-carnitine on the status of lipid peroxidation and antioxidants in aging rats. J. Nutr. Biochem., 1998, 9:pp. 575-581. |
Bertelli A, Conte A, Ronca G. L-propionyl carnitine protects erythrocytes and low density lipoproteins against preosidation . . . Drugs Explt. Clin. Res., 1994, 20:pp. 191-197. |
Hagan TM, Ingersoll RT, Wehr CM, et al. Acetyl-L-carnitine fed to old rats partially restores mitochondrial function and ambulatory activity. Proc National Academy of Sciences USA, 1998, 95:pp.9562-9566. |
Hagen TM, Yowe DL, Bartholomew JC, et al. Mitochondrial decay in hepatocytes from old rats: membrane potential declines, heterogeneity and oxidants increase. Proc National Academy of Sciences USA, 1997, 94: pp. 3064-3069. |
Hill K, The demography of menopause, Maturitas 1996, 23: pp. 113-127. |
Chan AC. Vitamin E and Atherosclrosis, J Nutr 1998, 128:pp. 1593-1596. |
Motoyama T, Kawano H, Kuggiyama K, et al. Vitamin E administratin improves impairment of endothelium-dependent vasodilation in patients with coronary spasmic angina. J Am Coll Cardiol 1998, 32:pp. 1672-1679. |
Meydani M, Lipman RD, Han SN, et al. The Effect of Long-term Dietary Supplementation with Antioxidants, Ann NY Acad Sci 1998, 854:Seddon JM, Ajani UA, Sperduto RD, et al. Dietary carotenoids, vitamins A, C and E and advanced age-related macular degeneration. Eye disease case-control study group. JAMA 1994, 272:pp. 352-360. |
Seddon JM, Ajani UA, Sperduto RD, et al. Dietary carotenoids, vitamins A, C and E, and advanced age-related macular degeneration. Eye disease case-control study group. JAMA 1994, 272: pp. 1413-1420. |
West S, Vitale S, Hallfrisch J, et al. Are antioxidants or supplements protective for age-related macular degeneration? Arch Opthalmol 1994, 112: pp. 1413-1420. |
Van der Hagen AM, Yolton DP, Kaminski MS and Yolton RL. Free radicals and antioxidant supplementation: a review of their roles in age-related macular degeneration. J Am Optom Assoc 1993, 112: pp. 222-227. |
Golberg J, Flowerdew G, Smith E, Brody JA, Tso MO. Factors associated with age-related macular degeneration. An analysis of data from first National Health and Nutrition Examination Survey. Am J Epidemiol 1988, 128:pp. 700-710. |
Sinclair AJ, Bayer AJ, Johnston J, Warner C, and Maxwell SR. Altered plasma antioxidant status in subjects with Alzheimer's disease and vascular dementia. Int. J. Geriatr Psychiatry 1998, 13: pp. 840-845. |
Morris MC, Beckett LA, Scherr PA, Herbert LE, et al. Vitamin E and vitamin C supplement use and risk of incident Alzeheimer disease Alzheimer Dis Assoc Disord 1998, 12: pp. 121-126. |
Subramaniam R, Koppal T, Green M, Yatin S, Jordan B, Drake J, and Butterfield DA. The free radical antioxidant vitamin E protects cortical synaptosomal membranes from amyloid beta-peptide (25-35) toxicity but not from hydroxynonenal toxicity: relevance to the free radical hypothesis of Alzheimer's disease. Neurochemical Research, 1998, 23:pp. 1403-1410. |
Hills, Prescription Diet Canine R/D, late 1998. |
Hills, Prescription Diet Feline R/D, late 1998. |